Literature DB >> 9789027

BRCA1 is associated with the centrosome during mitosis.

L C Hsu1, R L White.   

Abstract

Centrosomes and their associated microtubules direct events during mitosis and control the organization of animal cell structures and movement during interphase. The centrosome replicates during the cell cycle, directs the assembly of bipolar mitotic spindles, and plays an important role in maintaining the fidelity of cell division. Recently, tumor suppressors such as p53 and retinoblastoma protein pRB have been localized to the centrosome in a cell cycle-dependent manner. Immunofluorescence microscopy and analysis of isolated centrosomes now provide evidence that BRCA1 protein, a suppressor of tumorigenesis in breast and ovary, also is associated with centrosomes during mitosis. Our results indicate that BRCA1 localizes with the centrosome during mitosis and coimmunoprecipitates with gamma-tubulin, a centrosomal component essential for nucleation of microtubules. Furthermore, gamma-tubulin associates preferentially with a hypophosphorylated form of BRCA1.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9789027      PMCID: PMC23679          DOI: 10.1073/pnas.95.22.12983

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells.

Authors:  J P Vaughn; P L Davis; M D Jarboe; G Huper; A C Evans; R W Wiseman; A Berchuck; J D Iglehart; P A Futreal; J R Marks
Journal:  Cell Growth Differ       Date:  1996-06

2.  Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression.

Authors:  M E Thompson; R A Jensen; P S Obermiller; D L Page; J T Holt
Journal:  Nat Genet       Date:  1995-04       Impact factor: 38.330

3.  Cell synchronization.

Authors:  W Krek; J A DeCaprio
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

Review 4.  The centrosome and cellular organization.

Authors:  D R Kellogg; M Moritz; B M Alberts
Journal:  Annu Rev Biochem       Date:  1994       Impact factor: 23.643

5.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

6.  Both viral (adenovirus E1B) and cellular (hsp 70, p53) components interact with centrosomes.

Authors:  C R Brown; S J Doxsey; E White; W J Welch
Journal:  J Cell Physiol       Date:  1994-07       Impact factor: 6.384

7.  Pericentrin, a highly conserved centrosome protein involved in microtubule organization.

Authors:  S J Doxsey; P Stein; L Evans; P D Calarco; M Kirschner
Journal:  Cell       Date:  1994-02-25       Impact factor: 41.582

8.  In vitro reconstitution of centrosome assembly and function: the central role of gamma-tubulin.

Authors:  T Stearns; M Kirschner
Journal:  Cell       Date:  1994-02-25       Impact factor: 41.582

9.  Primary structure of NuMA, an intranuclear protein that defines a novel pathway for segregation of proteins at mitosis.

Authors:  D A Compton; I Szilak; D W Cleveland
Journal:  J Cell Biol       Date:  1992-03       Impact factor: 10.539

10.  NuMA is required for the proper completion of mitosis.

Authors:  D A Compton; D W Cleveland
Journal:  J Cell Biol       Date:  1993-02       Impact factor: 10.539

View more
  81 in total

1.  BRCA1-dependent ubiquitination of gamma-tubulin regulates centrosome number.

Authors:  Lea M Starita; Yuka Machida; Satish Sankaran; Joshua E Elias; Karen Griffin; Brian P Schlegel; Steven P Gygi; Jeffrey D Parvin
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

2.  Characterization of BRCA1 protein targeting, dynamics, and function at the centrosome: a role for the nuclear export signal, CRM1, and Aurora A kinase.

Authors:  Kirsty M Brodie; Beric R Henderson
Journal:  J Biol Chem       Date:  2012-01-18       Impact factor: 5.157

3.  Centrosomal Chk2 in DNA damage responses and cell cycle progression.

Authors:  Amnon Golan; Elah Pick; Lyuben Tsvetkov; Yasmine Nadler; Harriet Kluger; David F Stern
Journal:  Cell Cycle       Date:  2010-07-01       Impact factor: 4.534

4.  The CRM1 nuclear export protein in normal development and disease.

Authors:  Kevin T Nguyen; Michael P Holloway; Rachel A Altura
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

Review 5.  Centrosomes in the DNA damage response--the hub outside the centre.

Authors:  Lisa I Mullee; Ciaran G Morrison
Journal:  Chromosome Res       Date:  2016-01       Impact factor: 5.239

6.  Phosphorylated BRCA1 is predominantly located in the nucleus and mitochondria.

Authors:  Elisabeth D Coene; Michael S Hollinshead; Anouk A T Waeytens; Vera R J Schelfhout; Willy P Eechaute; Michael K Shaw; Patrick M V Van Oostveldt; David J Vaux
Journal:  Mol Biol Cell       Date:  2004-12-09       Impact factor: 4.138

Review 7.  Mitosis is not a key target of microtubule agents in patient tumors.

Authors:  Edina Komlodi-Pasztor; Dan Sackett; Julia Wilkerson; Tito Fojo
Journal:  Nat Rev Clin Oncol       Date:  2011-02-01       Impact factor: 66.675

Review 8.  TPX2: of spindle assembly, DNA damage response, and cancer.

Authors:  Gernot Neumayer; Camille Belzil; Oliver J Gruss; Minh Dang Nguyen
Journal:  Cell Mol Life Sci       Date:  2014-02-21       Impact factor: 9.261

9.  BRCA1 and FancJ cooperatively promote interstrand crosslinker induced centrosome amplification through the activation of polo-like kinase 1.

Authors:  Jianqiu Zou; Deli Zhang; Guang Qin; Xiangming Chen; Hongmin Wang; Dong Zhang
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 10.  Can the status of the breast and ovarian cancer susceptibility gene 1 product (BRCA1) predict response to taxane-based cancer therapy?

Authors:  J Thomas De Ligio; Aneliya Velkova; Diego A R Zorio; Alvaro N A Monteiro
Journal:  Anticancer Agents Med Chem       Date:  2009-06       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.